申请人:McConnell Darryl
公开号:US20100210644A1
公开(公告)日:2010-08-19
The present invention encompasses compounds of general formula (1) wherein the groups R
1
to R
5
are defined as in claim
1
, which are suitable for treating diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
本发明涵盖了一般式(1)中定义如权利要求1中的R1至R5基团的化合物,适用于治疗由过度或异常细胞增殖所特征的疾病,并且它们的用途是制备具有上述特性的药物。